Overview
Noora Andersson practices practicing medicine in Helsinki, Finland.
Her clinical expertise encompasses Ovarian Cancer, Biliary Atresia, Cholestasis, and Hepatoblastoma.
She is actively involved in clinical research, co-authoring 25 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Noora Andersson
Is Noora Andersson a top-rated expert for Ovarian Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Noora Andersson is classified as an Experienced expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Noora Andersson participate in research or clinical trials?
Yes. Noora Andersson has published 25 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Noora Andersson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Biliary AtresiaMs. Andersson isExperienced. Learn about Biliary Atresia.
- CholestasisMs. Andersson isExperienced. Learn about Cholestasis.
- HepatoblastomaMs. Andersson isExperienced. Learn about Hepatoblastoma.
- Ovarian CancerMs. Andersson isExperienced. Learn about Ovarian Cancer.